Evidence map›Paper›PMID 31679960›Full record

ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2020

The Unfulfilled Promise of the N170 as a Social Biomarker.

Alexandra P Key, Blythe A Corbett

Abstract read
In one paragraph

Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Characterizing the Relationship Among the Social Competence Elements in Autistic Adolescents.Autism research : official journal of the International Society for Autism Research · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Sex differences in automatic emotion regulation in adolescents with autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2022
    Article
  10. Refining biomarker evaluation in ASD.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021
    Article
  11. Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Alexandra P KeyVanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: sasha.key@vanderbilt.edu.
Blythe A CorbettVanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Psychology, Vanderbilt University, Nashville, Tennessee.

Funding

Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRELL, FRANK E. · 2015 to 2019
$7.1M
Peers, play and performance to improve social interaction in autismR34MH097793 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CORBETT, BLYTHE ANNE · 2013 to 2015
$706k
NICHD NIH HHS U54 HD083211NIMH NIH HHS R34 MH097793
6 · The paper itself

Abstract

backgroundGreater affordability and accessibility of noninvasive brain imaging techniques have led to an increased interest in identifying biomarkers of various cognitive processes, particularly in the field of neurodevelopmental disabilities. Autism spectrum disorder (ASD) is one area of research in which strong claims in support of brain-based biomarkers, such as the face-sensitive N170 event-related potential response, are currently emerging. This study systematically examined the possibility of the N170 amplitude and latency measures serving as a biomarker of social information processing in ASD.

methodsThe N170 response to faces and houses was recorded during passive picture viewing in 77 children with ASD, 7 to 16 years of age, at 2 time points (before and after a social skills intervention) 3 months apart. Social functioning was assessed using standardized behavioral tests, caregiver reports, and observational measures of naturalistic social interactions.

resultsThe results replicated prior findings of larger N170 amplitudes in response to faces than to houses, but the associations with the behavioral measures of social functioning were modest and not consistently present across the 2 assessment time points. Neither the amplitude nor the latency of the N170 response to faces was sensitive to the effects of a social skills intervention that produced behavioral improvements.

conclusionsThe N170 is a reliable event-related potential response reflecting the sensory-perceptual stage of face processing, but it does not fit the definition of a biomarker of social deficits in ASD because it is not sufficiently informative about heterogeneity of social functioning and is not sensitive to treatment effects.

Indexed as

Autism Spectrum DisorderEvoked PotentialsFacial RecognitionAdolescentBiomarkersChildElectroencephalographyElectronic Data ProcessingFemaleHumansMaleSocial BehaviorBiomarkersAutismBiomarkerFaceN170SocialTreatment

Identifiers

PMID31679960
PMCPMC7064396

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.